Currys
CURY · Main Market · Retail · mcap £1,543m · 144.6p 2 open situations →
Open · 2
£50m share buyback
The new £50m buyback began on 2 July 2026, after the prior £50m programme was completed in FY26, and is part of c.£85m planned cash returns for 2026/27. By 29 August £23m was done, and year-end net cash is expected well above the £100m target.
- New buyback
- £50m, commencing 2 July 2026
- Returns FY26
- £74m shareholder returns in the year
- Planned returns
- c.£85m total cash returns in 2026/27
- Dividend
- Final 2.25p; full year 3.0p, +100%; cover 4.5x
- Net cash floor
- At least £100m year-end net cash maintained
- Buyback size
- £50m, commenced 2 July 2026
Next: complete the £50m buyback; further returns at interim results · 17 Dec 2026
- 10 Sep 2026 £23m of £50m completed
- 2 Jul 2026 Prior buyback done; new £50m starts
- 19 May 2026 £74m returned to shareholders in the year; buyback completion not confirmed
- 21 Jan 2026 £30m of £50m done; £20m remaining
FY guidance and net cash
FY26 adjusted PBT of £191m beat the raised £180-190m guidance, and for 2026/27 the Group said it was comfortable with consensus. The 17-week update leaves guidance unchanged, with consensus at £199m (company-compiled), and net cash expected well above £100m. The next profit update follows Peak.
- FY adjusted PBT
- £191m, +18% YoY, above the £180-190m guidance
- Net cash
- Year end expected well above £100m target
- FY26/27 outlook
- Comfortable with market consensus; trading very solid
- Next milestone
- Profit update after Peak; interims on 17 December 2026
- Guidance
- All guidance unchanged; comfortable with market consensus
- Consensus
- Group adjusted PBT £199m (company-compiled, 9 September 2026)
Next: profit update after Peak trading period
- 10 Sep 2026 Guidance unchanged; consensus £199m
- 2 Jul 2026 Results confirmed £191m; comfortable with consensus
- 3 Jun 2026 Figures reconfirmed; results due 2 July
- 19 May 2026 Profit ahead of guidance at around £191m; net cash above £170m
Closed · 3
Company filings. Not investment advice.